On Feb. 7, AstraZeneca announced it received a Notice of Transfer to the Prosecutor and an Appraisal Opinion from the ...

Pascal Soriot (pictured) said innovation in pharma 'has mostly been funded by the US' as he doubled down on plans to grow the ...

CEO Soriot said Europe must boost investment in pharma innovation or risk falling further behind the US in drug development.

AstraZeneca has axed three MedImmune legacy monoclonal antibody drugs from its neuroscience pipeline in a first-quarter clear ...

Q1 2025 Management View CEO Pascal Soriot emphasized that AstraZeneca's total revenue grew by 10% in Q1 2025, with core operating profit increasing by 12% and core EPS by 21%. Growth was supported by ...

AstraZeneca (AZN) reported mixed first quarter earnings results, missing on revenue estimates but beating on earnings per ...

AstraZeneca ( AZN) CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on ...

It’s an incredibly exciting time for AstraZeneca in Canada,” says Gaby Bourbara, President, AstraZeneca Canada. “Since 2023, we have invested $4.3 billion in Canada’s l ...

The U.K. Centre for Process Innovation (CPI), says a new blueprint will help biopharmaceutical firms navigate a digital ...

AstraZeneca to discontinue CAPItello-280 phase III trial of Truqap in metastatic castration-resistant prostate cancer: Cambridge, UK Wednesday, April 30, 2025, 10:00 Hrs [IST] Ast ...

EMA committee recommends approval of AstraZeneca’s fixed-duration Calquence-based regimens for 1st-line chronic lymphocytic leukaemia: Cambridge, UK Wednesday, April 30, 2025, 1 ...

AstraZeneca has warned that countries must buy more of its cutting-edge medicines or jobs and investment will shift abroad.